Tuesday, November 1, 2011

This is the Way the World Ends

http://www.nytimes.com/2011/10/30/magazine/how-ready-are-we-for-bioterrorism.html?pagewanted=1&ref=magazine&adxnnlx=1320145648-K5idnXUdyKqBqlIIQsGvhw

The Bio-Defense establishment’s official position seems to be that a smallpox outbreak would be the worst case scenario bioattack. The article mentions a simulation of such an attack done a few years ago, which concluded that a million Americans would die. Calling this the “worst case” might be right if the simulation were modified to “a genetically engineered smallpox outbreak”—the toll would be higher. No one knows by how much!

Diseases can be “improved” for virulence or communicability or survivability or vaccine resistance or treatment resistance—or, theoretically, any other imaginable traits—by means of genetic manipulations. This has been possible since the 70s. And, today, it’s not even difficult to modify diseases. It is difficult, however, to achieve genetic modifications that will produce desired results. That is, transposing genes within an organism’s DNA, as a mechanical operation, is cheap and easy. Finding out which modifications will “improve” the beast remains difficult and expensive because so many non-linear variables come into play, and precise calculation of their interactions is impossible—the Soviets had to do extensive animal testing to determine what effects various modifications would have when exposed to animal immune systems and the natural environment. So, the worst case might involve a more virulent, more communicable disease not susceptible to conventional treatment, a disease that might kill far more than a million Americans. Even back in the 60s, per the article, before genetic engineering was possible, America had achieved weaponized tularemia (presumably by means of rapid, selective, experimentally-guided evolution) to the point that 50 pounds of it, properly disseminated, would wipe out 60% of a megacity.  

Protection against crude attacks with unmodified agents may well provide a high probability of effective defense for a couple more decades (though something more than a black swan risk is present already). The Muslim world is unlikely to muster anything but amateur-hour efforts within this time frame. Attacks from other quarters are improbable. But, back to the lingering black swans. The thing is, there are multiple black swan risks out there. A sample of contingencies: an accidental release of a bio-agent from a government lab (dozens of governments work on dangerous pathogens, offensively or defensively, and America alone has dozens of such labs), a pathogen developed in an “entrepreneur’s” garage and released, a deliberate release into the environment that escapes intended limits (eg, a controlled test of pathogen characteristics), a government employee deliberately steals, then sells or releases a bio-agent.   

The article discusses the dilemma of whether to focus resources on vaccine defenses or therapeutic defenses. Yet it fails to mention one of the prime determinants of the relative efficacy of these two approaches: the impact of the threat of genetically modified disease agents. Do vaccines against the variola major strain of small pox, for example, have a high probability of success against a genetically modified variant of the disease? And how difficult, in the context of a bio-arms race, would it be to develop small pox variants that would resist a known, stockpiled vaccine? I suspect the answers to these questions, if they’ve been considered and if they’re knowable, are classified.

The article concludes with a hint at the clash between political decision-making processes and cost-benefit processes. What translates into political capital tends to starve ugly, obscure issues until the piper comes round at last. “How to balance the unlikely but catastrophic potential of bioterror with the steady advance of natural disease is one of the most puzzling challenges for biodefense policy going forward.” This is an unavoidable question, except I would say the “steady retreat of natural disease.” The only significant inroads natural disease has made in the last 100 years are those related to poor nutrition—consequent upon mere stupidity (including the stupidity or conspiracy of doctors) and torpor. Natheless, sichlike common health issues, never out of sight and never out of mind, exert great gravitational pull on the common politician.  

Another part of the problem seems to be a matter of bureaucratic influence on policy decisions—like this Fauci genius spending 70% of biodefense funding on common diseases afflicting public health. Fauci is a public health bureaucrat, not a defense bureaucrat—so he spends what he can on public health. Bureaucrats generally fit the mold of defective wind-up toys—little action, no thought. Also, moving up a notch to the political sphere, it’s lovely to discover that Obama has ended centralized direction of biodefense. What we have is a few part-timers in the White House overseeing the program and trying to coordinate multiple mutually antagonistic bureaucracies. Well, I suppose it’s over-optimistic to expect Obama to take an interest in something other than handouts and labor unions.   


After such knowledge, what forgiveness? Think now
History has many cunning passages, contrived corridors
And issues, deceives with whispering ambitions,
Guides us by vanities. Think now
She gives when our attention is distracted
And what she gives, gives with such supple confusions
That the giving famishes the craving. Gives too late
What’s not believed in, or if still believed,
In memory only, reconsidered passion. Gives too soon
Into weak hands, what’s thought can be dispensed with
Till the refusal propagates a fear. Think
Neither fear nor courage saves us. Unnatural vices
Are fathered by our heroism. Virtues
Are forced upon us by our impudent crimes.
These tears are shaken from the wrath-bearing tree.

--Gerontion